Clinical trials
Observational Lymphoma, B-Cell, Marginal Zone trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
33 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2005 | 2 |
| 2006 | 4 |
| 2007 | 2 |
| 2008 | 8 |
| 2009 | 4 |
| 2010 | 2 |
| 2018 | 1 |
| 2022 | 1 |
| 2024 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Terminated | 8 |
| Recruiting | 6 |
| Active, not recruiting | 3 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Vanderbilt-Ingram Cancer Center | 4 |
| City of Hope Medical Center | 3 |
| Mayo Clinic | 3 |
| Case Comprehensive Cancer Center | 2 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2 |
| UNC Lineberger Comprehensive Cancer Center | 2 |
| Vanderbilt University | 2 |
| Adicet Therapeutics | 1 |
| Bristol-Myers Squibb | 1 |
| Children's Oncology Group | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, B-Cell, Marginal Zone | 33 |
| Lymphoma, Mantle-Cell | 30 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 29 |
| Lymphoma, Follicular | 28 |
| Lymphoma, Non-Hodgkin | 27 |
| Lymphoma, Large B-Cell, Diffuse | 26 |
| Burkitt Lymphoma | 25 |
| Lymphoma, Large-Cell, Immunoblastic | 25 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 24 |
| Lymphoma | 22 |
Trials
Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.